Admin Suppl to examine the role of Vit E Acetate in ENDS
Admin Suppl to examine the role of Vit E Acetate in ENDS
批准号:
10060130
负责人:
Farrah Kheradmand
金额:
$21.2万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2021-07-31
关键词:
AcuteAcute respiratory failureAdultAlveolar MacrophagesAntigen-Presenting CellsBiochemicalCannabisCarbon BlackCase StudyCessation of lifeChemicalsChildChronicClinicalDNA AdductionDermatologicDiagnosisDyspneaElectronic Nicotine Delivery SystemsElectronic cigaretteEpithelial CellsExperimental ModelsExposure toFatigueFundingGenesGlycerolHomeostasisHumanImmuneInhalationInhalation ExposureInvestigationLinkLipidsLiquid substanceLungLung diseasesModelingMusNational Institute of Environmental Health SciencesNicotineParentsPatientsPlayPneumoniaPre-Clinical ModelPropylene GlycolsProteinsPulmonary EmphysemaPulmonary Surfactant-Associated Protein APulmonary Surfactant-Associated Protein DPulmonary SurfactantsReportingRespiratory FailureRespiratory Signs and SymptomsRoleSamplingSchool-Age PopulationSkinSmokeSmokerSolventsTestingTobaccoToxic effectToxicologyVegetablesViralVitamin EVitamin E AcetateWorkalveolar epitheliumcigarette smokecigarette smokingcohorte-cigarette aerosolselectronic cigarette useelectronic cigarette userelectronic liquidinsightmacrophagemarijuana usermouse modelnanosizednovelparticlepathogenpreclinical studyrespiratoryresponsesurfactantvapingvapor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Electronic cigarettes (ecigs) gained popularity in never- and active-smokers who are persuaded by intense ad
campaigns that brands their use as a healthy alternative to cigarette smoke. Whether heated vaporized contents in
ecigs, e.g., propylene glycol (PG), vegetable glycerol (VG) with or without nicotine, are safe alternatives to
cigarette smoking remains unknown. We have developed a robust mouse model of conventional and ecig exposure
and made several novel discoveries that provide unique insights into the toxicology of ecig in the lungs. In the
first year of our funding, we have shown that the popular ecig solvents (e.g., 60/40 ratio of PG/VG), independent
of nicotine, can alter lung lipid homeostasis and disrupt the function of alveolar macrophages and epithelial cells
(Madison et al, JCI, 2019). We showed that ecig exposure can result in increased abundance of endogenous lipid
species normally found in the lung lining fluid, but surfactant proteins (SP)-A, and SP-D associated with these
lipids are significantly reduced. Several recent reports have described sporadic cases of ecig (nicotine, and/or
cannabis) users who presented with a mysterious (non-infectious) type of lipoid pneumonia. These respiratory
illnesses are clinically characterized by dyspnea, fatigue, and in most severe form, respiratory failure and death.
Currently the causative factor(s) for the acute respiratory failure in ecig users remains unknown, however the
FDA reported that over ½ of the ecig liquid samples linked to the hospitalized patients tested positive for Vitamin
E (Vit E) acetate. In this supplemental application, we request funding to examine the acute and chronic effects
of Vit E acetate inhalation to determine whether they play a causative role in lung toxicity. We propose the
following two Specific Aims: Aim 1. To determine the effect of acute and chronic inhalational exposure to
Vitamin E acetate in mice. We have found that independent of nicotine, lung surfactant composition in mice
exposed to chronic ecig is altered. The cannabis-containing ecig liquid used by a number of patients who presented
with acute respiratory failure, contains Vit E acetate, a common solvent used in dermatological products. Using
our well established ecig model, we will determine if acute (two weeks) or chronic (two months) exposure to Vit
E acetate alone or in combination with PG/VG can alter surfactant in the lungs. Aim 2. To determine whether
acute or chronic inhalation of Vitamin E acetate alters the function of macrophages and/or epithelial cells
in the lungs. A common clinical feature of reported cases in several hundred ecig users who have presented with
respiratory failure, is the diagnosis of lipoid pneumonia which is characterized by the presence of abnormal lung
macrophages that contain large amounts of intracytoplasmic lipids. Given that Vit E acetate, has been found in
ecig products used by over half of the cases associated with severe respiratory disease, we hypothesize that it can
synergize with the common solvents in ecig to induce cellular toxicity in lung immune and or epithelial cells.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1213/ane.0000000000005273
发表时间:
2021-07-01
期刊:
Anesthesia and analgesia
影响因子:
5.7
作者:
[Chandrakantan A, Adler AC, Tohsun M, Kheradamand F, Ray RS, Roth S]
通讯作者:
Roth S
DOI:
10.1016/j.matbio.2018.03.005
发表时间:
2018-11
期刊:
Matrix biology : journal of the International Society for Matrix Biology
影响因子:
--
作者:
[Zhou Y, Horowitz JC, Naba A, Ambalavanan N, Atabai K, Balestrini J, Bitterman PB, Corley RA, Ding BS, Engler AJ, Hansen KC, Hagood JS, Kheradmand F, Lin QS, Neptune E, Niklason L, Ortiz LA, Parks WC, Tschumperlin DJ, White ES, Chapman HA, Thannickal VJ]
通讯作者:
Thannickal VJ
Cardiopulmonary Consequences of Vaping in Adolescents: A Scientific Statement From the American Heart Association.
青少年吸电子烟对心肺的影响:美国心脏协会的科学声明。
DOI:
10.1161/res.0000000000000544
发表时间:
2022
期刊:
Circulation research
影响因子:
20.1
作者:
[Wold,LorenE, Tarran,Robert, CrottyAlexander,LauraE, Hamburg,NaomiM, Kheradmand,Farrah, StHelen,Gideon, Wu,JosephC, AmericanHeartAssociationCouncilonBasicCardiovascularSciences, CouncilonArteriosclerosis,ThrombosisandVascularBiolo]
通讯作者:
CouncilonArteriosclerosis,ThrombosisandVascularBiolo
Laryngeal inflammatory response to smoke and vape in a murine model.
小鼠模型中对烟雾和电子烟的喉部炎症反应。
DOI:
10.1016/j.amjoto.2018.10.001
发表时间:
2019
期刊:
American journal of otolaryngology
影响因子:
2.5
作者:
[Ha,Tu-AnhN, Madison,MatthewC, Kheradmand,Farrah, Altman,KennethW]
通讯作者:
Altman,KennethW
DOI:
10.1016/j.matbio.2018.03.012
发表时间:
2018-11
期刊:
Matrix biology : journal of the International Society for Matrix Biology
影响因子:
--
作者:
[Gu BH, Madison MC, Corry D, Kheradmand F]
通讯作者:
Kheradmand F
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures
-
批准号:10383650
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Farrah Kheradmand
-
依托单位:
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures
-
批准号:9774557
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Farrah Kheradmand
-
依托单位:
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures
-
批准号:10553621
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Farrah Kheradmand
-
依托单位:
Toxic Effects of Ecigs Following Transition From Conventional Cigarettes
-
批准号:9982334
-
项目类别:
-
资助金额:$44.75万
-
财政年份:2018
-
负责人:Farrah Kheradmand
-
依托单位:
Ancillary T Cell Based Studies in SPIROMICS
-
批准号:8266804
-
项目类别:
-
资助金额:$38.15万
-
财政年份:2012
-
负责人:Farrah Kheradmand
-
依托单位:
Ancillary T Cell Based Studies in SPIROMICS
-
批准号:8794458
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2012
-
负责人:Farrah Kheradmand
-
依托单位:
Ancillary T Cell Based Studies in SPIROMICS
-
批准号:8604407
-
项目类别:
-
资助金额:$39.39万
-
财政年份:2012
-
负责人:Farrah Kheradmand
-
依托单位:
Ancillary T Cell Based Studies in SPIROMICS
-
批准号:8424239
-
项目类别:
-
资助金额:$39.59万
-
财政年份:2012
-
负责人:Farrah Kheradmand
-
依托单位:
VIRAL-INDUCED T CELL RESPONSES IN COPD EXACERBATION PROTOCOL: LES COPD
-
批准号:8356768
-
项目类别:
-
资助金额:$6.29万
-
财政年份:2010
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Adaptive Immunity in Human COPD and Emphysema
-
批准号:8195974
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Acquired Immunity in Human COPD and Emphysema
-
批准号:9336809
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Acquired Immunity in Human COPD and Emphysema
-
批准号:8732293
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
VIRAL-INDUCED T CELL RESPONSES IN COPD EXACERBATION PROTOCOL: LES COPD
-
批准号:8166763
-
项目类别:
-
资助金额:$6.98万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Adaptive Immunity in Human COPD and Emphysema
-
批准号:8259372
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Adaptive Immunity in Human COPD and Emphysema
-
批准号:7782707
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Innate and acquired immune responses in human COPD
-
批准号:10225981
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Acquired Immunity in Human COPD and Emphysema
-
批准号:8867863
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Adaptive Immunity in Human COPD and Emphysema
-
批准号:7686519
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
VIRAL-INDUCED T CELL RESPONSES IN COPD EXACERBATION PROTOCOL
-
批准号:7950688
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2008
-
负责人:Farrah Kheradmand
-
依托单位:
LONGITUDINAL EXACERBATION STUDY OF COPD (LES COPD)
-
批准号:7605943
-
项目类别:
-
资助金额:$2.37万
-
财政年份:2007
-
负责人:Farrah Kheradmand
-
依托单位:
海外基金